In this video produced by Healio at the International Liver Congress 2016, where DNDi launched its new Research & Development Strategy for Hepatitis C, Bernard Pécoul, Executive Director of DNDi, discusses the launch of a new partnership between DNDi and Pharco Pharmaceuticals that aims to bring hepatitis C viral infection testing and treatment, for under $300, to low- and middle-income patients in certain parts of Asia.
Watch the Video
